Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes
NCT00544206 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2008-09-23
Summary
To compare the glucose response in tube fed subjects with type 2 diabetes of a standard enteral product to that of a diabetes-specific enteral product
Conditions
Interventions
- OTHER
-
standard enteral feeding product
16 hrs daily x 5 days
- OTHER
-
Diabetes specific feeding product
16 hrs daily for 5 days
Sponsors & Collaborators
-
Abbott Nutrition
lead INDUSTRY
Principal Investigators
-
Gordon Sacks, PhD · University of Wisconsin, Madison
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2008-08-31
- Completion
- 2008-09-30
Countries
- United States
Study Locations
More Related Trials
-
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740 ·Status: UNKNOWN ·Phase: NA
-
To Determine Tolerability to Glucagon Infusion in Obese Subjects
NCT02817659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies
NCT06173934 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
NCT03544229 ·Status: COMPLETED ·Phase: PHASE2
-
Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes
NCT02669524 ·Status: COMPLETED ·Phase: NA
-
Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion
NCT01030952 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Intermediate Care Clinics for Diabetes
NCT00945204 ·Status: COMPLETED ·Phase: NA
-
DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery
NCT00641251 ·Status: COMPLETED ·Phase: NA
-
The Impact of Glucotoxicity on Gastric Emptying in Chinese Patients With Newly Diagnosed Type 2 Diabetes
NCT05284344 ·Status: COMPLETED
-
Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Malnutrition
NCT05913193 ·Status: COMPLETED
-
Insulin Therapy in Type 2 Diabetic Patients: Real-life Study on Effectiveness and Satisfaction
NCT06117449 ·Status: NOT_YET_RECRUITING
-
Clinical Evaluation of a Specific Enteral Diet for Diabetics
NCT01247714 ·Status: UNKNOWN ·Phase: NA
-
The Role of the Duodenum in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Mellitus
NCT00568620 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Low Carbohydrate Diet and Traditionally Recommended Diabetic Diet in the Treatment of Diabetes Mellitus Type 2.
NCT01005498 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Low Glycemic Index Diet in Patients With Type 1 Diabetes
NCT01184703 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of GLP-1 Receptor Agonists on Trabecular Bone Score
NCT04964388 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes
NCT00200018 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
NCT04965051 ·Status: UNKNOWN ·Phase: NA
-
A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes
NCT04118374 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis
NCT01557296 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States
NCT02987335 ·Status: COMPLETED
-
Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin
NCT02033876 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes
NCT01435980 ·Status: UNKNOWN ·Phase: PHASE4
-
Glucose Variability in Subclinical Hypertrophy
NCT02748434 ·Status: TERMINATED ·Phase: NA